METABASIS THERAPEUTICS INC
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Other material eventJan 28, 2010
- Entered a material agreementDec 17, 2009
- Entered a material agreementDec 2, 2009
- Entered a material agreement · Director / officer change · Other material eventOct 28, 2009
- Director / officer changeOct 20, 2009
- Director / officer changeOct 13, 2009
- Delisting / listing-standard notice · Other material eventSep 18, 2009
- Delisting / listing-standard noticeSep 9, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15-12GMar 15, 2010
- SC 13G/AFeb 16, 2010
- SC 13G/AFeb 16, 2010
- SC 13G/AAMENDMENT NO. 2 TO THE SCHEDULE 13GFeb 3, 2010
- SC 13D/AFeb 2, 2010
- EFFECTJan 29, 2010
- EFFECTJan 29, 2010
- EFFECTJan 29, 2010
- EFFECTJan 29, 2010
- EFFECTJan 29, 2010
- 4MAIN DOCUMENT DESCRIPTIONJan 29, 2010
- 4MAIN DOCUMENT DESCRIPTIONJan 29, 2010
- S-8 POSPOST- EFFECTIVE AMENDMENT NO. 1 TO FORM S-8Jan 28, 2010
- S-8 POSPOST- EFFECTIVE AMENDMENT NO. 1 TO FORM S-8Jan 28, 2010
- S-8 POSPOST- EFFECTIVE AMENDMENT NO. 1 TO FORM S-8Jan 28, 2010
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.